Inclusion and exclusion criteria
PICC to be inserted for medical treatment.
Informed consent.
Vascular size sufficient to support 4-Fr PICC or larger.
Previous enrolment in the current study.
Current catheter-related bloodstream infection.
Thrombosis in vein where PICC is to be inserted.
Non-English speaking without an interpreter.
Known sensitivity to study products (including CHG).
Added since trial commencement: admitted for COVID-19, or to a designated COVID-19 unit/facility.
CHG, chlorhexidine gluconate; Fr, French; PICC, peripherally inserted central catheter.